4 Feb 2015 11:26
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
SYR.L Share News (SYR)
SYR Share
Price
SYR Share
News
SYR Share
Chat
SYR Share
Trades
SYR
Live RNS
SYR Share
Charts
SYR Broker
Ratings
SYR Directors
Deals
SYR Financial
Diary
SYR
Fundamentals
SYR Short
Positions
SYR
Media
SYR.L Information
- There is currently no data for SYR
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Synergy Health rockets as US court thwarts FTC's attempt to block Steris deal
Fri, 25th Sep 2015 07:25
(ShareCast News) - Shares in Synergy Health rocketed on Friday after it announced that a federal court in Ohio has ruled against the Federal Trade Commission's request for a preliminary injunction to block Steris' $1.9bn acquisition of the group."We are pleased that the Court has agreed with our position and we will be working to close the transaction with Steris Corporation as quickly as possible," said chief executive officer Dr Richard Steeves."We believe that this is a strategically sensible deal that is beneficial to our customers, employees and our shareholders, creating new opportunities for growth with our combined strengths".In May, the Federal Trade Commission filed a lawsuit to stop the deal, saying it would both companies' customers by reducing competition between them based on innovative sterilisation techniques. "There is really very little conditionality left now - all that needs to be done to close this deal is the approvals of both sets of shareholders, who vote on Friday 2 October," said Olivetree Securities. "Expect to see Synergy trading as if this is realistically a done deal now," it added.At 0857 BST, Synergy shares were up 44% at 2,265p.
More News
4 Feb 2015 09:03
London open: Stocks retreat from five-month high, Hargreaves Lansdown falls
London's blue-chip stocks pulled back from a five-month high on Wednesday morning as investors watched developments in Greece and service-sector data from across the globe. The FTSE 100 was down 0.2% at 6,857 early on, as strong gains from Sky and a host of pharmaceutical stocks were outweighed by f
Read more4 Feb 2015 07:42
Synergy Health builds momentum in third quarter
Healthcare outsourcer Synergy Health said it was on track to hit full-year forecasts after growth momentum picked up strongly in the third quarter. The provider of sterilisation services, which is currently undergoing a takeover by US rival Steris Corp, said revenues increased by 11.5% to £105.6m in
Read more15 Oct 2014 15:53
FTSE 250 movers: CSR leads on buy-out deal
CSR shares leapt after fellow chip designer Qualcomm announced it was buying out the company for 900p a share or £1.56bn - a 36% premium to Tuesday's closing price. Infrastructure group Balfour Beatty saw its share price jump after appointing Qinetiq's chief executive officer Leo Quinn to take up th
Read more14 Oct 2014 09:17
Tuesday broker round-up UPDATE
Anglo Pacific: FinnCap upgrades to buy with a target price of 158p. Peel Hunt shifts target price from 196p to 198p retaining its buy recommendation. Ashmore: Canaccord Genuity upgrades from sell to hold with a target price of 300p. Numis cuts target price from 369p to 355p retaining an add rating.
Read more13 Oct 2014 17:00
London close: Mining stocks help lift FTSE to positive finish
Coming off the morning's declines, London-listed stocks ended Monday's session on a relatively upbeat note, thanks to a strong performance by the mining sector on what was a generally quiet day for markets. The FTSE 100 finished near its best levels of the session, closing 26.27 points higher at 6,3
Read more13 Oct 2014 15:27
FTSE 250 movers: Synergy Health soars on Steris Corp buy-out
Synergy Health shares rocketed after it was announced US-based medical technology group Steris Corp. had agreed to buy the UK company for $1.9bn. Synergy shareholders will be paid 439p a share in cash and 0.4308 shares in the newly combined group, valuing shares in the FTSE 250 group at £1.2bn, or 1
Read more